Lometrexol disodium is an antifolate agent with anticancer activity; it inhibits glycinamide ribonucleotide formyltransferase (GARFT), suppresses de novo purine synthesis, leading to aberrant cell proliferation, apoptosis, and cell cycle arrest; it is also a potent inhibitor of human serine hydroxymethyltransferase 1/2 (hSHMT1/2).